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Objective: To investigate the cytotoxic activity of the hexane and ethyl acetate extracts
of Curcuma mangga rhizomes against human colorectal adenocarcinoma cell lines
(HT29).
Methods: The cytotoxic activity of the hexane and ethyl acetate extracts of Curcuma
mangga rhizomes against human colorectal adenocarcinoma cell lines (HT29) was
determined by using the SRB assay.
Results: The ethyl acetate extract showed a higher cytotoxic effect compared to the
hexane extract. Morphological changes of the HT29 cells such as cell shrinkage, mem-
brane blebbling and formation of apoptotic bodies while changes in nuclear morphology
like chromatin condensation and nuclear fragmentation were observed. Further evidence
of apoptosis in HT29 cells was further supported by the externalization of phosphati-
dylserine which indicate early sign of apoptosis.
Conclusions: The early sign of apoptosis is consistent with the cell cycle arrest at the G0/
G1 checkpoint which suggests that the changes on the cell cycle lead to the induction of
apoptosis in HT29.1. Introduction
Colorectal cancer (CRC) can be deﬁned as one of the cancer
where it begins either in the colon or in rectum. CRC is
commonly found on the epithelial lining of the large intestine or
rectum. More than 95% of CRCs are adenocarcinomas. The
origin of CRC is from the epithelial lining of the gastrointestinal
tract and it is formed when normal colon/rectum cell undergoes a
sequential of mutation on speciﬁc genetic material that altered
the normal cell proliferation mechanism [1]. CRC is a common
type cancer which was accounted for ten percent of all cancer
in worldwide in year 2008 and 2012 [2]. In Peninsular
Malaysia, The risk factors that inﬂuences the occurrences of
CRC are included lifestyle habit, diet, genders, races andgenetic factors [3]. There are no early signs and symptoms of
CRC during the early stages but the symptoms will be shown
as the cancer grows in the late stage of CRC. The common
symptoms are changes of bowel habit, rectal bleeding,
stomach-ache, stomach cramping, weight loss and tiredness.
The common treatments for CRC are chemotherapy, surgery,
radiotherapy or combined treatments [4].
Curcuma mangga (C. mangga) is a species of rhizomes plant
under the family of Zingiberaceae. It is locally known as ‘temu
pauh’ in Malaysia while in Indonesia, it is known as ‘temu
mangga’ or ‘kunir putih’ and ‘Khamin khao’ in Thailand [5]
because of the pleasant mango-scent rhizomes. Rhizomes and
leaves of C. mangga had been reported to have cytotoxic activity
and antiproliferation effects on breast adenocarcinoma, colo-
rectal adenocarcinoma [6], oral carcinoma, lung adenocarcinoma,
cervical carcinoma, colorectal carcinoma [7], ductal carcinoma
[8,9], prostate carcinoma, lung carcinoma [10] and gastric
adenocarcinoma [11,12]. Rhizomes and leaves extracts of
C. mangga also possessed antioxidant [13–15], anti-
inﬂammatory [16] and antimicrobial activities [17]. However,
the mechanism of cell death on cancer cell induced by extracts
of C. mangga has not been widely elucidated. Only one report
by Karsono et al. (2014) demonstrated cell death throughcle under the CC BY-NC-ND license (http://
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(PC)-3 induced by ethanolic extracts of C. mangga [18].
One of the hallmarks of cancer is resistance to programmed
cell death or apoptosis [19]. Biochemical and morphological
measures can be used to characterize apoptosis, such as
pyknosis, chromatin condensation, and formation of apoptotic
bodies [20], cell shrinkage [21], DNA fragmentation [22] and
structure disruption of membrane [23]. In this communication,
the induction of apoptosis of the hexane and ethyl acetate
extracts of the rhizomes of C. mangga is reported.
2. Materials and methods
2.1. Plant material
The rhizomes of the C. mangga were obtained from Yogja-
karta, Indonesia in July 2012. A voucher specimen (voucher
number: HI 1331) was deposited in the Herbarium of the
Institute of Biological Sciences, Faculty of Science, University
of Malaya.
2.2. Preparation of CME and CMH extracts
The hexane (CMH) and ethyl acetate (CME) extracts of
C. mangga rhizomes were obtained according to the method of
Malek et al. [7]. Brieﬂy, the dried, ground and powdered
rhizomes C. mangga (1.0 kg) was soaked in methanol
(2.0 mL) for three days at room temperature and yielded
106.4 g of dark brown methanol extract (10.6%) after
removal of the solvents using a rotary evaporator. The
methanol extract was further fractionated consecutively with
n-hexane, ethyl acetate and water to yield 35.7 g of hexane
extract (33.6% of methanol extract), 30.1 g of dark brown
ethyl acetate extract (28.3% of methanol extract) and 7.4 g of
light brown water extract (7.0% of extract). CMH and CME
extracts of C. mangga were prepared in dimethyl sulfoxide
(DMSO) to obtain the 40.0 mg/mL stock solution for
sulforhodamine B (SRB) cytotoxicity assay. A stock solution
of both extracts was diluted to the required concentrations
with Roswell Park Memorial Institute (RPMI 1640) medium
to a ﬁnal concentration of DMSO below 0.1% during the
experiment.
2.3. Cell culture
Human colorectal adenocarcinoma cell lines (HT-29) and
human normal colon cell lines (CCD-18Co) were purchased
from American Type Culture Collection (ATCC, USA). Basic
medium for culture of HT-29 and CCD-18Co cells was RPMI
1640 medium and minimum essential medium (MEM)Table 1
IC50 values of CME, CMH and cisplatin on HT29 and CCD-18Co.
Cell Type Time
HT29 Human colorectal adenocarcinoma 2
4
7
CCD-18Co Normal human colon 7
Results are shown as mean ± SE from three independent experiments.respectively. Both basic medium were supplemented with L-
glutamine and other supplements such as fetal bovine serum,
amphotericin B, penicillin/streptomycin, sodium pyruvate and
non-essential amino acid solution. All basic mediums and
supplements were purchased from Sigma–Aldrich, USA. HT-
29 cells was cultured in RPMI 1640 medium supplemented
with 10.0% fetal bovine serum, 2.0% of penicillin/strepto-
mycin and 1.0% of amphotericin B while CCD-18Co was
cultured in MEM medium supplemented with 20.0% fetal
bovine serum, 2.0% of penicillin/streptomycin and 1.0% each
for amphotericin B, sodium pyruvate and non-essential amino
acid solution. All cells were grown in 25 cm3 tissue culture
ﬂasks (Corning, USA). Both cell lines were incubated and
maintained in incubator (Esco, Model: CCL-170B-8) under
condition of humidiﬁed 5.0% CO2 atmosphere at 37 C. When
the cell achieved 80%–90% conﬂuent, it was detached by
accutase and sub-cultured into new sterile culture ﬂasks for
further propagation.
2.4. SRB cytotoxicity assay
A ﬂask of conﬂuent cells was detached and cell at density of
3.0 × 104 cells/mL were seeded onto 96-well plates and the
seeded suspension cells attached in the wells after 24 h of in-
cubation. After the incubation of 24 h, the media were discarded
and stock solution of samples (CMH and CME) was diluted into
various concentrations (ranging from 1.0 mg/mL–100.0 mg/mL)
with the medium. The ﬁnal concentration of DMSO in all wells
did not exceed 0.1%. The treated cells were incubated for 24, 48
and 72 h at 37 C in incubator. The untreated well was served as
negative control. SRB assay was conducted as described by
Houghton et al. (2007) with modiﬁcations. After the incubation
period (24, 48 and 72 h), 50.0 mL of 40.0% (v/v) trichloroacetic
acid (TCA) was added to each well and kept at 4.0 C for an
hour. The medium containing TCA was discarded and the plates
were added with 50.0 mL of distilled water to remove the excess
TCA in the wells. The washing process was repeated by
replaced fresh distilled water for 4 times. Next, 50.0 mL of 0.4%
(w/v) SRB dye (Sigma) was added into well and the plates were
incubate in room temperature for 30 min. The excess SRB dye
was removed and washed the plates with 50.0 mL of 1% (v/v)
acetic acid for 5 times. 100.0 mL of 10 mM of Tris Base was
added in the plates and the plate was agitated for 500 rpm in the
Thermo Shaker, BioSan, Latvia for 5 min to solubilise the bound
SRB dye in every well. The absorbance reading was then
calculated by using a microplate reader (Synergy H1 Hybrid) at
wavelength 570 nm and 630 nm as background. The IC50 was
calculated by comparing the percentages of absorbance of
treated cell with untreated cells (control) [24,25]. The assays were
conducted in triplicates.(h) IC50 (mg/mL)
CMH CME Cisplatin
4 39.3 ± 6.0 32.2 ± 2.7 –
8 21.7 ± 0.8 32.1 ± 2.6 –
2 17.9 ± 1.2 15.6 ± 0.8 8.9 ± 1.2
2 45.7 ± 1.0 46.5 ± 0.5 5.5 ± 0.5
Figure 1. Morphological changes of cells under phase-contrast microscopy at 40× magniﬁcation.
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Phase contrast microscopy: Cells were seeded in sterile 24-
well plate at a cell density of 3.0 × 104 cells/mL and the cells
were incubated for 24 h to allow adherence of cells. Then the
cells were treated with both extracts at three concentrations(20.0 mg/mL, 30.0 mg/mL and 40.0 mg/mL) and incubated for
24, 48 and 72 h in CO2 incubator. The morphological changes of
the treated cells included cell shrinkage; blebbing of membrane;
cell detachment and rounding were observed. The image of
morphological changes of the cells was captured at 40×
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Vert, A1).
Fluorescence microscopy: Hoechst 33342/propidium iodide
(PI) double staining method was used to observe the cell nu-
clear morphological changes in ﬂuorescence microscopy [26].
The procedures in cell seeding and treatments were similar
with the previous experiment with phase contrast microscopy.
After the incubation period, the media in the plates were
removed and the cells were harvested. Both media and
harvested cells were collected and then centrifuged at
1500 rpm for 5 min. The cell pellets were washed with ice-
cold phosphate buffer saline (PBS) solution and re-suspended
with PBS solution. The cell suspensions were then incubated
with Hoechst 33342 in the dark at 37 C and humidiﬁed 5%
CO2 incubator for 7 min. Then PI was added into the cell
suspension and further incubated in the dark under for 15 min at
room temperature. Ices were used to deactivate and stabilize the
activity of Hoechst dye. The cell samples were loaded on a slide
and the morphology of cells was examined under Leica, Ger-
many DM16000B ﬂuorescent microscope. The image of nu-
clear morphological changes of the cells was captured at 40×
magniﬁcations.
2.6. Detection of early and late apoptosis through
binding of Annexin Ⅴ to phosphatidylserine
Detection of early and late apoptosis by binding of Annexin
Ⅴ to phosphatidylserine (PS) was analyzed using a ﬂow cy-
tometer. The overall cell apoptosis detection procedures were
similar to Ho et al. (2013) with slight modiﬁcation on the cell
numbers [27]. Brieﬂy, 1.2 × 105 cells/mL was plated and treated
with 3 different concentrations (20.0, 30.0 and 40.0 mg/mL) for
24, 48 and 72 h in triplicates. The cells were harvested into
15.0 mL centrifuge tubes and washed with PBS. Cell pelletFigure 2. Nuclear morphology changes observed on HT29 treated with CMH
Arrows represent (1) Live cell with normal nuclei, (2) Live cell with apoptotic
nuclei.was re-suspended with Annexin-Ⅴ binding buffer and trans-
ferred into 1.5 mL centrifuge tube. Suspended cells were
stained with Annexin-Ⅴ and propidium iodide for 15 min in the
dark at room temperature. Annexin-Ⅴ binding buffer was later
added into stained cells to deactivate the staining process of
Annexin-Ⅴ and propidium iodide. Detection of apoptosis was
performed using Accuri C6 ﬂow cytometer. For each mea-
surement, 10000 events were counted where cell population
was distributed into different quadrants and each quadrant was
analysed with quadrant statistics. Lower left quadrant repre-
sented viable cells; lower right quadrant represented early
apoptotic cell; and upper right quadrant represented late
apoptotic or necrotic cells.
2.7. Cell cycle analysis
The cell cycle analysis procedure was according to Ho et al.
(2013) with slight modiﬁcations [27]. Brieﬂy, HT29 cells were
plated at cell number of 3.0 × 105 cells/mL and treated with
both extracts for 72 h in triplicates. The cells were harvested,
washed and then ﬁxed with 70% ethanol. The cell ﬁxation
took overnight time in −20 C freezer. The next day, the ﬁxed
cells were centrifuged to become pellet, washed with ice-cold
PBS and re-suspended with staining buffer containing 50 mg/
mL of propidium iodide, 0.1% Triton-X-100, 0.1% sodium
citrate, and 100 mg/mL of RNase. The cell suspension was
incubated in the dark condition for 30 min at room temperature.
The stained cell was then analyzed with Accuri C6 ﬂow
cytometer.
2.8. Statistical analysis
All results were expressed as mean ± SD and all the ex-
periments were performed at least twice using sampleafter 72 h using double staining Hoechst 33342/PI at magniﬁcation of 40×.
nuclei, (3) Dead cell with normal nuclei, and (4) dead cell with apoptotic
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SPSS Statistics 22.0 software. t-test was performed to deter-
mine the signiﬁcant differences between the treated cell and
non-treated cell. P < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Effects of CMH and CME extracts on cell growth
inhibition of human colorectal adenocarcinoma (HT29)
and normal human colon cell lines (CCD-18Co)
Results from SRB cytotoxicity assay showed that growth
inhibitory effect against HT29 cells by both hexane and ethyl
acetate extracts of C. mangga rhizomes increase in both dose-
and time-dependent manner. Table 1 showed the half maximal
inhibitory concentration (IC50) of CMH, CME and cisplatin
(positive control) on HT29 and CCD-18Co cells at dose-
dependent manner.Figure 4. Nuclear morphology changes in a single cell.
(a) In negative control, most of the cells are viable with normal nuclei and lowe
most of the cells undergo early apoptosis (b) and secondary necrosis (c) or lat
Figure 3. Nuclear morphology changes observed on HT29 treated with CME af
Arrows represent (1) Live cell with normal nuclei, (2) Live cell with apoptotic
nuclei.3.2. CMH and CME extracts induced changes of cell
morphology in HT29 cells
Phase contrast microscopy on HT29 cells showed the
presence of ﬂoating or detachment of non-viable cells in dose-
and time-dependent manners (Figure 1). Others morphological
changes on treated HT29 cells were cell shrinkage, cell
membrane blebbing and formation of apoptotic bodies. The
detachment of non-viable cells and other morphological
changes were similar in HT29 cells treated with both CMH and
CME extracts.
The nuclear morphology changes in HT29 cells were
observed through the ﬂuorescence emissions from the nuclei of
the cells after 72 h of treatment with both extracts. Nuclear
morphological changes were observed by Hoechst 33342/PI
double staining assay. Figures 2 and 3 shows viable cells in the
negative control displays lower intensity blue ﬂuorescence
emission (Hoechst 33342 dye), where treated cells showed
higher intensity of blue ﬂuorescence emission and slight pink
ﬂuorescence (PI dye) in the nucleus. Figure 4 shows the nuclear
morphology changes in a single cell.r intensity blue ﬂuorescence emission (Hoechst 33342 dye). In treated cells,
e apoptosis (d).
ter 72 h using double staining of Hoechst 33342/PI at magniﬁcation of 40×.
nuclei, (3) Dead cell with normal nuclei, and (4) dead cell with apoptotic
Figure 5. Early cell apoptosis detection by Annexin-Ⅴ/PI staining.
(a) CMH increased apoptotic cells signiﬁcantly at 20 mg/mL, 30 mg/mL and 40 mg/mL. Compared to the untreated control, treated cells showed statistically
signiﬁcant (P < 0.05). An increase in the percentage of apoptotic cells was observed after treatment for 24 h, 48 h, and 72 h. (b) HT29 cells were treated with
CMH at 20 mg/mL, 30 mg/mL, and 40 mg/mL for 24 h, 48 h, and 72 h. The lower left quadrant show viable cell population, the lower right quadrant show
early apoptotic cell population, the upper right show late apoptotic or necrotic cell and the upper left show necrotic cell.
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apoptosis in HT29 cells
Figures 5 and 6 showed the results of early and late cell
apoptosis detection by Annexin-Ⅴ/PI staining. The extracts
induced apoptosis in dose- and time-dependent manner. The
population of early apoptotic cells (Annexin-Ⅴ single positivecells) increased from (6.4 ± 0.5)% (control) to (21.7 ± 0.3)%,
and (29.9 ± 0.5)% for cells treated with 30 mg and 40 mg/mL. As
for CME treated HT29 cells, the population of early apoptotic
cells increased from (4.9 ± 0.2)% (control) to (9.5 ± 0.6)%,
(13.5 ± 0.1)%, and (22.3 ± 0.1)% after 72 h treatment with 20,
30 and 40 mg/mL of extracts respectively. The population of late
apoptotic cells (Annexin-Ⅴ/PI double positive cells) in CMH
Figure 6. Late cell apoptosis detection by Annexin-Ⅴ/PI staining.
(a) CME has increased the induction of apoptotic cells signiﬁcantly at 30 mg/mL and 40 mg/mL. Compared to the untreated control, treated cells showed
statistically signiﬁcant (P < 0.05). An increase in the percentage of apoptotic cells was observed after treatment for 24 h, 48 h, and 72 h. (b) HT29 cells were
treated with CME at 20, 30, and 40 mg/mL for 24, 48, and 72 h. The lower left quadrant show viable cell population, the lower right quadrant show early
apoptotic cell population, the upper right show late apoptotic or necrotic cell and the upper left show necrotic cell.
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Figure 7. Effects of CMH on cell cycle distribution on HT29 cells.
(a) Cells were treated with CMH at different concentrations. Compared to the untreated control, treated cells showed statistically signiﬁcant, especially after
72 h of treatment (P < 0.05). (b) Cell cycle distribution of untreated cells. (c) Cell cycle distribution at 20 mg/mL. (d) Cell cycle distribution at 30 mg/mL. (e)
Cell cycle distribution at 40 mg/mL.
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(11.1 ± 0.3)%, (17.1 ± 1.3)% and (25.8 ± 0.4)% while in CME
treated cells, the population of late apoptotic cells increased from
(5.6 ± 0.3)% (control) to (13.0 ± 0.7)%, (17.3 ± 0.5)% and
(28.8 ± 0.5)% after 72 h treatment with 20, 30 and 40 mg/mL of
extracts respectively.
3.4. Effects of CMH and CME on cell cycle distribution
on HT29 cells
CME at concentration 30 and 40 mg/mL and CMH at con-
centration 40 mg/mL caused accumulation of cells in G0/G1
phase and G2/M phase in HT29 cells where the percentages cells
in the S phase was signiﬁcantly reduced (Figures 7 and 8). Thepercentages of cells which accumulated in the G0/G1 phase after
treatment with CME, increased from (62.13 ± 1.33)% (control)
to (63.10 ± 3.35)%, (67.11 ± 2.51)% and (68.49 ± 1.26)% in 20,
30 and 40 mg/mL respectively. In the G2/M phase, the accu-
mulation of cells increased from (4.99 ± 0.91)% (control) to
(6.78% ± 1.61)%, (15.69 ± 1.32)% and (18.02 ± 0.87)% when
treated with increasing concentration of CME (20–40 mg/mL).
The percentages of cell accumulation in G0/G1 phase treated
with CMH increased from (67.11 ± 2.51)% at 30 mg/mL to
(79.83 ± 0.46)% at 40 mg/mL. For cells percentage accumulated
in G2/M phase, the cells increased from (6.32 ± 0.88)% (con-
trol), (9.42% ± 2.55)%, (9.99 ± 3.41)% and (18.12 ± 0.67)%
when treated with increasing concentration of CMH (20–40 mg/
mL).
Figure 8. Effects of CME on cell cycle distribution on HT29 cells.
(a) Cells were treated with CME at different concentrations. Compared to the untreated control, treated cells showed statistically signiﬁcant, especially after
72 h of treatment (P < 0.05). (b) Cell cycle distribution of untreated cells. (c) Cell cycle distribution at 20 mg/mL. (d) Cell cycle distribution at 30 mg/mL. (e)
Cell cycle distribution at 40 mg/mL.
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This report attempts to investigate the mechanism of induc-
tion of apoptosis induced by ethyl acetate and hexane extracts of
C. mangga on HT29 cells. The toxicity of both extracts on
normal colon cell line, CCD-18Co was evaluated as well. Up to
date, this is the ﬁrst report on the induction of apoptosis by
C. mangga extracts on HT29 cells.
Both CMH and CME possessed good cytotoxic activity
against HT29 cells with IC50 value of (15.6 ± 0.8) mg/mL and
(17.9 ± 1.2) mg/mL respectively in comparison to cisplatin
(positive control) with IC50 value of (8.9 ± 1.2) mg/mL. Dose-
and time-dependent cytotoxicity of both extracts on HT29 cells
was observed where percentage of cell proliferation inhibition
increased as the dose of extracts and exposure periods to extractsincreased. Both extracts possessed mild toxicity on the normal
colon cell lines, CCD-18Co, [IC50 value of (46.5 ± 0.5) mg/mL
and (45.7 ± 1.0) mg/mL respectively] in comparison with
cisplatin with IC50 value of (5.5 ± 0.5) mg/mL. Toxicity on the
normal tissue of human body is the main problem to the clinical
efﬁcacy of chemotherapy [27,28]. Therefore, from the ﬁrst
discovery stages of drug until the mass scale production, one
of the biggest requirements in anticancer drug development is
the particularly high number of safety precaution in
conducting of the drug substance [29].
Phase-contrast microscopy revealed early sign of morpho-
logical changes of cell apoptosis such as cell shrinkage, mem-
brane blebbing and formation of apoptotic bodies [20,23,30]. The
result showed cell detachment from the bottom surface of culture
plate after the cells were exposed to both extracts for 24, 48 and
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and fragmentation were observed under ﬂuorescence which were
the characteristics of cell apoptosis [21].
Annexin-Ⅴ staining was performed to detect the early and
late apoptosis in treated HT29 cells. Annexin-Ⅴ dye can easily
bind to the externalized phosphatidylserine on the outer plasma
membrane of apoptotic cells [21]. The presence of PS on the cell
surface is one of the most signiﬁcant characteristics in apoptosis
due to the negative charge phospholipid with its ability to
modify the interactions with other lipids that might disrupts
the lipid supporting structures [31]. During occurrences of early
apoptosis, the cell membrane asymmetry is disrupted causing
the exposure of PS residues to outer cell membrane leaﬂet
[32,33]. Cells in the kate apoptosis on secondary necrosis are
both Aneexin and PI positive. Detection of early and late
apoptosis in HT29 cells after treated by CMH and CME are
conﬁrmed by positive Annexin-Ⅴ staining cells in dose- and
time dependent manners.
This is further supported by the results from cell cycle
analysis where cells were treated with both extracts were
arrested in the G0/G1 phase. G1 phase arrest correlated with the
regulation of tumour protein, p53 [34–36] and other proteins
such as p21, CDK2 and CDK4. Lin et al. (2007) reported
that meclizine caused arrest of cell cycle at the G0/G1 phase
of human colorectal carcinoma (HCT116 cells) by up-
regulating the p53 and p21/CIP1 proteins which in-turn sup-
pressed the activities of CDK2 and CDK4 kinase activities [37].
p53 was recognized as the protein which control G1 phase
which will either induce cell arrest in G1 phase, or reunite
begins with apoptosis [38]. Therefore, arrest in G1 phase
create the chances of cells to enter repair phase or undergoes
apoptosis for maintaining tissue homoeostasis [39]. Karsono
et al. (2014) also showed similar effects on cell distribution
in prostatic epithelial cells, PC3, where cells arrest occurred
in G0/G1 phase when treated with 70% ethanol extract of
C. mangga [18]. The effect on the cell cycle progression may
be contributed by an array of bioactive compounds present in
them. Chemical investigations on extracts of C. mangga
revealed that many of the isolated compounds are labdane-
type diterpenoids [7,12,40]. The biosynthetic pathway for
labdane-type diterpenoids is selective for this species as
diterpenoids are rarely reported present in Curcuma species
[40].
Based on this study, extracts of C. mangga rhizomes dis-
played inhibitory effects and which able to induce apoptosis
on HT29 cell line. Both extracts also caused cell cycle arrest
of the HT29 cells in the G0/G phase. The mechanism of
apoptosis on HT29 cells should be further investigated.
However, this study showed that both extracts could be po-
tential candidates in the development of natural products for
anticancer therapy.
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